{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:22:01Z","timestamp":1778800921745,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.vaccine.2015.09.050","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T04:57:59Z","timestamp":1444021079000},"page":"7008-7014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses"],"prefix":"10.1016","volume":"33","author":[{"given":"Irina","family":"Kiseleva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Dubrovina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Larionova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Isakova\u2013Sivak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Bazhenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pisareva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Kuznetsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.09.050_bib0225","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01573-15","article-title":"Evolutionary dynamics and global diversity of influenza A virus","author":"Rejmanek","year":"2015","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.09.050_bib0230","doi-asserted-by":"crossref","first-page":"433","DOI":"10.18388\/abp.2014_1861","article-title":"Influenza A viruses of avian origin circulating in pigs and other mammals","volume":"61","author":"Urbaniak","year":"2014","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0235","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00840-15","article-title":"Molecular epidemiology and evolution of influenza viruses circulating within European swine between 2009 and 2013","author":"Watson","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0240","unstructured":"Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. 2014, WHO. Available at: (http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20140727CumulativeNumberH5N1cases.pdf?ua=1((accessed 20 January 2015)."},{"key":"10.1016\/j.vaccine.2015.09.050_bib0245","unstructured":"WHO risk assessment of human infection with avian influenza A(H7N9) virus. 2014, WHO. Available at: (http:\/\/www.who.int\/entity\/influenza\/human_animal_interface\/influenza_h7n9\/riskassessment_h7n9_27june14.pdf?ua=1) (accessed 20 January 2015)."},{"issue":"7337","key":"10.1016\/j.vaccine.2015.09.050_bib0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/471157a","article-title":"Vaccinate for the next H2N2 pandemic now","volume":"471","author":"Nabel","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2015.09.050_bib0255","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S0022172400062860","article-title":"Antibody status to influenza A\/Singapore\/1\/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses","volume":"95","author":"Pyhala","year":"1985","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0260","unstructured":"WHO global action plan to increase vaccine supply for influenza vaccines. 2006, Geneva, Belgium. WHO\/IVB\/06.13. WHO\/ODS\/EPR\/GIP\/2006.1. Available at: (http:\/\/whqlibdoc.who.int\/hq\/2006\/WHO_IVB_06.13_eng.pdf) (accessed 20 January 2015)."},{"issue":"4","key":"10.1016\/j.vaccine.2015.09.050_bib0265","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/infdis\/168.4.881","article-title":"Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia","volume":"168","author":"Rudenko","year":"1993","journal-title":"J Infect Dis"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2015.09.050_bib0270","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0264-410X(00)00153-5","article-title":"Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents","volume":"19","author":"Rudenko","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.09.050_bib0275","first-page":"77","article-title":"Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3\u201314-year-olds","volume":"74","author":"Rudenko","year":"1996","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2015.09.050_bib0280","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0264-410X(93)90194-3","article-title":"Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987\/88","volume":"11","author":"Slepushkin","year":"1993","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2015.09.050_bib0285","first-page":"A40","article-title":"Live attenuated pandemic influenza vaccine: clinical studies on A\/17\/California\/2009\/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries","volume":"29","author":"Rudenko","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.09.050_bib0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1750-2659.2008.00064.x","article-title":"Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I\u2013II clinical trials)","volume":"2","author":"Rudenko","year":"2008","journal-title":"Influenza Respir Viruses"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1750-2659.2008.00056.x","article-title":"Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza","volume":"2","author":"Ambrose","year":"2008","journal-title":"Influenza Respir Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2015.09.050_bib0300","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1542\/peds.2006-0725","article-title":"Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care","volume":"118","author":"Vesikari","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2015.09.050_bib0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.inf.0000116292.46143.d6","article-title":"Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination","volume":"23","author":"Zangwill","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2015.09.050_bib0310","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.inf.0000109392.96411.4f","article-title":"Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents","volume":"23","author":"Bergen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2015.09.050_bib0315","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338363","article-title":"Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study","volume":"185","author":"Neuzil","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-12-385034-8.00003-X","article-title":"Influenza vaccines: the good, the bad, and the eggs","volume":"77","author":"Schultz-Cherry","year":"2010","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0325","unstructured":"WHO Technical report. Avian influenza portfolio. Collected risk assessments, technical guidance to public health authorities and advice to the general public. Stockholm, June 2006. Available at: (https:\/\/www.google.ru\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CBwQFjAA&url=http%3A%2F%2Fecdc.europa.eu%2Fen%2Fpublications%2FPublications%2F0606_TER_Avian_Influenza_Portafolio.pdf&ei=c0GZVJrXMKj8ygODt4CYCw&usg=AFQjCNGBBamHmZOAqcROvIVZ66GcCY_6jw&sig2=XW6kPJ9093ObKy9j1WSWkA&bvm=bv.82001339,d.bGQ&cad=rjt) (accessed 20 January 2015)."},{"issue":"12","key":"10.1016\/j.vaccine.2015.09.050_bib0330","doi-asserted-by":"crossref","first-page":"e114637","DOI":"10.1371\/journal.pone.0114637","article-title":"The possible impact of vaccination for seasonal influenza on emergence of pandemic influenza via reassortment","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2015.09.050_bib0335","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1586\/14760584.2014.922417","article-title":"Development of live attenuated influenza vaccines against pandemic influenza strains","volume":"13","author":"Coelingh","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0340","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.vaccine.2009.05.099","article-title":"Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults","volume":"27","author":"Karron","year":"2009","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2015.09.050_bib0345","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2009.03.082","article-title":"A live attenuated H7N3 influenza virus vaccine is well-tolerated and immunogenic in a phase I trial in healthy adults","volume":"27","author":"Talaat","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0350","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-2659.2012.00350.x","article-title":"An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults","volume":"7","author":"Talaat","year":"2013","journal-title":"Influenza Respi Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2015.09.050_bib0355","doi-asserted-by":"crossref","first-page":"e87962","DOI":"10.1371\/journal.pone.0087962","article-title":"Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine","volume":"9","author":"Rudenko","year":"2014","journal-title":"PloS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2015.09.050_bib0360","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/21645515.2015.1010859","article-title":"H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers","volume":"11","author":"Isakova-Sivak","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.08.019","article-title":"Clinical testing of pre-pandemic live attenuated A\/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study","author":"Rudenko","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0370","unstructured":"Proposed WHO recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal administration. WHO Technical report Series No. 977, 2013. Available at: (http:\/\/www.who.int\/biologicals\/areas\/vaccines\/influenza\/TRS_977_Annex_4.pdf) (accessed 20 January 2015)."},{"key":"10.1016\/j.vaccine.2015.09.050_bib0375","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1016\/j.vaccine.2012.09.076","article-title":"Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains","volume":"30","author":"Kiseleva","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2015.09.050_bib0380","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.inf.0000220229.51531.47","article-title":"A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine","volume":"25","author":"Vesikary","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0385","unstructured":"Desheva JA, Rudenko LG, Rekstin AR, Swayne D, Cox NJ, Klimov AI. Development of candidate H7N3 live attenuated cold-adapted influenza vaccine. In: (Ed.), Proceedings of the International Conference on Options for the Control of Influenza VI; 2007 June 17-23 Toronto, Ontario, Canada; Atlanta International Medical Press London 2002. 591-2."},{"issue":"7","key":"10.1016\/j.vaccine.2015.09.050_bib0390","doi-asserted-by":"crossref","first-page":"e102339","DOI":"10.1371\/journal.pone.0102339","article-title":"Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus","volume":"9","author":"Isakova-Sivak","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0395","first-page":"8","article-title":"Live attenuated influenza vaccines against highly pathogenic H5N1 avian influenza: development and preclinical characterization","volume":"4","author":"Larionova","year":"2013","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0400","unstructured":"WHO Manual on animal influenza diagnosis and surveillance. 2002, WHO. Available at: (http:\/\/www.who.int\/csr\/resources\/publications\/influenza\/whocdscsrncs20025rev.pdf) (accessed 20 January 2015)."},{"issue":"3","key":"10.1016\/j.vaccine.2015.09.050_bib0405","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0410","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1099\/vir.0.017996-0","article-title":"PB2 and PA genes control the expression of the temperature sensitive phenotype of cold-adapted B\/USSR\/60\/69 influenza master donor virus","volume":"91","author":"Kiseleva","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0415","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-61779-621-0_7","article-title":"The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors","volume":"865","author":"Hurt","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0420","unstructured":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility. Geneva, November 2011 and June 2012. Wkly Epidemiol Rec 2012;87:369\u201374."},{"key":"10.1016\/j.vaccine.2015.09.050_bib0425","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristic of influenza virus at 25\u00b0C","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0430","first-page":"179","article-title":"Obtaining of an additionally attenuated vaccinating cryophilic influenza strain","volume":"2","author":"Alexandrova","year":"1965","journal-title":"Rev Roum Inframicrobiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.09.050_bib0435","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Isakova-Sivak","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.09.050_bib0440","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T02:58:58Z","timestamp":1567220338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15013262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":44,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0264410X15013262"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}